Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced a nationwide open casting call in search of the next Faces of Natrelle®, encouraging women who have experienced breast reconstruction and ...
Hosted on MSN21h
MedPharm appoints Bill Humphries as new CEOMedPharm has appointed Bill Humphries as its new CEO, marking a significant step in the company's strategic growth. The move ...
Europe medical device market was valued at $144.4 billion in 2022 and will grow by 4.7% annually over 2022-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of ...
North America medical device market is projected to grow by 3.9% annually in the forecast period and reach $ 282.3 billion by 2032, driven by the prevalence of infectious diseases as well as the ...
The adoption of telemedicine and remote monitoring technologies in ophthalmology to accelerate the market growth, says Fact.MR in its new market rese ...
AbbVie launched a revamped version of its Allē loyalty program, which ultimately was not adopted by providers. The marketing ...
Good morning, and thank you for standing by. Welcome to the AbbVie fourth-quarter 2024 earnings conference call. (Operator Instructions) Today's call is also being recorded. If you have any objections ...
AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback